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Abstract
Studies have suggested that red and processed meat consumption elevate the risk of colon cancer;
however, the relationship between red meat, as well as fat and protein, and distal colorectal cancer
(CRC) specifically is not clear. We determined the risk of distal CRC associated with red and
processed meat, fat, and protein intakes in Whites and African Americans. There were 945 cases
(720 White, 225 African American) of distal CRC and 959 controls (800 White, 159 African
American). We assessed dietary intake in the previous 12 mo. Multivariate logistic regression
analyses were used to obtain odds ratios (OR) and 95% confidence intervals (95% CI). There was
no association between total, saturated, or monounsaturated fat and distal CRC risk. In African
Americans, the OR of distal CRC for the highest category of polyunsaturated fat intake was 0.28
(95% CI = 0.08–0.96). The percent of energy from protein was associated with a 47% risk
reduction in Whites (Q4 OR = 0.53, 95% CI = 0.37–0.77). Red meat consumption in Whites was
associated with a marginally significant risk reduction (Q4 OR = 0.66, 95% CI = 0.43–1.00). Our
results do not support the hypotheses that fat, protein, and red meat increase the risk of distal
CRC.
INTRODUCTION
Colorectal cancer (CRC) is the third most common cancer in the United States and accounts
for approximately 9% of all cancer deaths (1). Diet is widely believed to be associated with
CRC development and is a modifiable risk factor. Therefore, there is great interest in better
understanding which dietary factors may be associated with higher or lower CRC risk. In
particular, increased consumption of dietary fat and protein (mainly animal fat and protein)
has shown strong correlations with CRC cancer incidence in ecological studies (2–5).
Observational studies in the United States have generally reported that high intakes of red
meat and processed meat may increase risk for CRC (6,7). A comprehensive review by the
World Cancer Research Fund and the American Institute for Cancer Research concluded
that there was convincing evidence that red meat and processed meat increases CRC risk but
that the evidence regarding the role of foods containing animal fat is limited (8). Several
hypotheses have been proposed to explain a possible relationship between red meat and
CRC risk. These hypotheses relate to primary nutrients in red meat, that is, fat (9–11),
protein (3,12), and heme iron (13) as well as components of processed red meat such as N-
nitroso compounds (9,14) and factors produced while cooking red meat at high
temperatures, namely, heterocyclic amines and polycyclic aromatic hydrocarbons (3,5,9,14).
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CRC consists of carcinomas of the colon and rectum, and rectal cancer comprises
approximately one-third of all colorectal cancers. It has been suggested that there are
different etiologies for colon and rectal cancer (15,16). CRC risk factors are thought to differ
according to the proximal versus distal location of the cancer in the colorectum. Therefore, it
is important to examine risk factors separately for both sites. Some investigators have
studied associations between meat intake and subsites of the colorectum (17–19) and have
suggested a stronger positive relationship between red meat and rectal cancer than red meat
and colon cancer (9). We previously observed nonstatistically significant inverse
associations with rectal cancer risk for high intakes of red meat in Whites and African
Americans, whereas processed meat had a nonstatistically significant positive association
with risk only among Whites (20). However, the currently available evidence regarding the
associations of fat and protein with distal colorectal cancer risk remains inconclusive.
To expand our previous findings, in the present study, we examined associations of fat and
protein intake, in addition to red and processed meat, with risk for distal CRC in African
Americans and Whites in a large case-control study in North Carolina (NC). We further
sought to examine the effect of fat and protein intake on the association between red and
processed meat and distal CRC. This study adds to the literature in 2 ways: it contributes to
the body of knowledge regarding diet and distal CRC risk and is, to our knowledge, the first
study to examine these associations in African Americans.
MATERIALS AND METHODS
Study Design and Population
The North Carolina Colon Cancer Study–Phase II is a population-based study conducted
between May 2001 and September 2006. Cases and controls were selected through a
randomized recruitment approach that used age-, sex-, and race-specific incidence rates to
calculate selection probabilities (21,22). African Americans were oversampled to increase
their representation in the study. The eligibility criteria for all subjects were age 40 to 79 yr,
resident in 1 of 33 target counties in central and eastern NC, a NC driver’s license, no
history of colon or rectal cancer, able to give informed consent, and able to complete the
interview.
Distal CRC cases (including sigmoid colon, rectosigmoid, and rectal cancer) were selected
through the rapid ascertainment system (23) of the NC Central Cancer Registry. Cases were
diagnosed with a primary adenocarcinoma between May 2001 and September 2006. Our
study pathologist confirmed these diagnoses using pathology slides and medical records.
Controls were randomly selected from the NC Department of Motor Vehicles if under age
65 and the Centers for Medicare and Medicaid Services if 65 and older.
A total of 1,057 out of 1,417 eligible cases and 1,019 out of 1,827 eligible controls had an
interview. Among those eligible to participate, the overall response rate (number
interviewed/number eligible) for cases was 74% (76% for Whites, 70% African Americans)
and 56% in controls (58% for Whites, 46% for African Americans). For this analysis, we
further excluded 89 participants who did not complete all components of the study and an
additional 86 participants who had implausible energy intake values (<800 kcal/day and
>5,000 kcal/day for men and <600 kcal/day and >4,000 kcal/day for women (24). The final
analytic sample included 945 cases (720 White, 225 African American) and 959 controls
(800 White, 159 African American). This study was approved by the Institutional Review
Board at the University of North Carolina at Chapel Hill.
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Data Collection
The National Cancer Institute’s (NCI) Diet History Questionnaire (DHQ) was used to assess
dietary intake. The DHQ is a 124-item food frequency questionnaire that includes questions
on dietary supplement use and fat added to foods (25,26). The questionnaire was
administered by trained nurse interviewers who asked subjects to recall their usual dietary
intake over the 1 yr prior to diagnosis for cases or interview for controls. Nutrient intakes
were determined using software provided by the NCI and were based on the nutrient content
of each food item, the frequency of consumption, and portion size. The nutrients/foods of
interest for this study were total fat, saturated fat, monounsaturated fat (MUFA),
polyunsaturated fat (PUFA), protein, red meat, and processed meat. Red meat includes non-
processed veal, lamb, beef steaks, beef roast, beef mixtures, burgers, ham (not luncheon
meat), pork, and ribs; and processed meat includes sausage, bacon, hot dogs, and all cold
cuts (i.e., luncheon meats made from beef, veal, ham, pork, chicken, and turkey).
Interviewers administered a separate questionnaire to collect data on covariates including
demographic and household information, medical history, medication use, physical activity,
smoking status, and family history of CRC.
Statistical Analysis
Analyses were conducted using SAS (version 9.1; SAS Institute, Inc., Cary, NC) and based
on 2-sided P values. Participants were stratified by race and case-control status. The
Wilcoxon nonparametric rank sum test was used to assess differences in mean nutrient
intakes between White and African American controls. We calculated adjusted odds ratios
(OR) and 95% confidence intervals (95% CI) using unconditional logistic regression
models. PROC LOGISTIC in SAS was used with an option in the MODEL statement to
include offsets. The offset term takes into account the selection probabilities based on age,
race, and sex, which were used to identify eligible participants (22). Quartiles (Q) were
constructed for nutrient and red meat intakes based on the distribution among race-specific
controls for stratified analyses. This was done to account for possible differences in the
variation in range of intake for Whites and African Americans. The following covariates
were considered for inclusion in the multivariate models: age (continuous), sex, education
(≤ high school, some college, college graduate/advanced degree), smoking status (never,
current, former), prior body mass index (BMI; i.e., in the 1 yr prior to interview for controls
and diagnosis for cases: normal, overweight, obese), physical activity (continuous), first
degree family history of CRC (yes, no), nonsteroidal anti-inflammatory drug (NSAID) use
(yes, no), calcium (continuous), folate (continuous), and fiber (continuous). The standard
multivariate method was used to adjust for total energy intake; the use of other methods
(e.g., nutrient residuals) did not appreciably alter the results. Multivariate models were
created using backward elimination and included covariates that changed the ORs of interest
by ≥10%. All covariates met the criteria for inclusion except smoking status and folate. P
values for trend were obtained using the median intake values in controls of each quartiles as
a continuous variable in the model, which was weighted by the inverse of the variance. For
each meat category, we constructed 3 multivariate models: model 1 included age, sex,
education, prior BMI, family history, NSAID use, physical activity, calcium, fiber, and total
energy; model 2 consisted of the covariates in model 1 and energy-adjusted saturated fat;
model 3 consisted of the covariates in model 1 and energy-adjusted protein. We examined
these 3 different models to determine the extent to which the association between red and
processed meat and distal CRC can be attributed to overall saturated fat or protein intake
since it has been suggested that these nutrients in red and processed meat contribute to the
elevated risk of CRC. Therefore, these 3 different model specifications test the hypothesis
that fat and protein intake mediate the association between red and processed meat and distal
CRC.
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RESULTS
Table 1 summarizes characteristics of cases and controls by race with respect to potential
confounders and dietary intake. Cases in both race groups were younger, had less education,
and a higher mean BMI than their respective controls (20). Among Whites, regular use of
NSAIDs was much more frequent in controls compared to cases, and a greater proportion of
African American cases had a family history of CRC than African American controls. Some
nutrient intakes and meat consumption patterns varied by race; among controls, on average,
Whites had significantly greater calcium, fiber, and alcohol intakes than African Americans.
There were no appreciable differences by race in total energy, dietary folate, and fat. The
percent of energy from protein was greater for Whites, although absolute intakes did not
differ significantly by race. Whites reported a slightly higher mean intake of red meat than
African Americans (52.1 vs. 50.1 g/day, respectively; P = 0.05), whereas African Americans
had greater processed meat consumption than Whites (24.5 vs. 18.7 g/day, respectively; P =
0.006).
As shown in Table 2, absolute intakes of total fat and the percent of energy from total fat
had null associations with risk in Whites and nonstatistically significant inverse associations
in African Americans. The ORs for saturated fat and the percent of energy from saturated fat
were not statistically significant in either race group; however, we observed a significant
inverse trend in African Americans for the percent of energy from saturated fat (P value for
trend = 0.004). With regards to the unsaturated fats (MUFA and PUFA), there were no
statistically significant associations with risk in Whites. In African Americans, the highest
category of PUFA intake was suggestive of lower risk (OR = 0.28, 95% CI = 0.08–0.96), yet
there was not a significant linear trend. There was an inverse association for high protein
intake in Whites only. In Whites, high absolute protein intake was suggestive of lower distal
CRC risk (OR = 0.57, 95% CI = 0.32–1.01); whereas high percent of energy from protein
also yielded a significant risk reduction (OR = 0.53, 95% CI = 0.37–0.77), and the ORs
decreased progressively with increasing percent of energy from protein (P value for trend =
0.003). Although the point estimates were of a similar magnitude in African Americans,
there was less statistical power to detect a statistically significant association.
Table 3 shows the relationship between distal CRC risk and red meat and processed meat.
The model 1 ORs for the highest category of red meat consumption were similar in both
race groups, yet only approached statistical significance in Whites (OR = 0.66, 95% CI =
0.43–1.00). There was a slightly stronger risk reduction in Whites when we controlled for
energy from saturated fat (OR = 0.60, 95% CI = 0.39–0.93). Moderately high processed
meat consumption had a significant positive association with risk in Whites (Q3 vs. Q1 OR
= 1.43, 95% CI = 1.02–2.02), which was even stronger when we adjusted for energy from
protein (Q3 vs. Q1 OR = 1.56, 95% CI = 1.10–2.20). However, neither Q4 ORs for
processed meat nor the P value for a linear trend were statistically significant. There were no
statistically significant associations in African Americans, although ORs suggest lower risk
for both red and processed meat.
DISCUSSION
In this large case-control study of 945 distal CRC cases (including sigmoid colon,
rectosigmoid, and rectal cancers) and 959 controls, we did not find any evidence of
associations between total and saturated fat and distal CRC risk, although PU-FAs appeared
to reduce risk in African Americans. Protein intake was associated with lower risk of distal
colorectal cancer in Whites. Our study does not support the hypothesis that high red meat or
processed meat consumption increases the risk of distal colorectal cancer. Interestingly, our
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findings suggest that red meat consumption may reduce the risk of distal CRC in Whites,
whereas moderately high intakes of processed meat possibly elevate risk.
The results for total fat intake are in agreement with several previous case control (27,28)
and cohort (29,30) studies, which have generally found no statistically significant
association with rectal cancer risk. Several investigations found the relationship between
overall fat intake and rectal cancer to vary by gender. For example, an early study by
Freudenheim et al. (31) observed an approximately twofold higher rectal cancer risk in
males (OR = 1.96, 95% CI = 1.19–3.24) but no clear association in females. Similarly, a
more recent and larger case-control study in Canada found a positive association among
male participants (OR = 1.7, 95% CI = 1.1–2.6) but no association in females (32). We did
not find evidence of effect modification by gender in our analyses of total fat and distal
CRC.
When examining the association between dietary fat and distal colorectal cancer, it is
important to consider different types of fatty acids because they can have different and
opposite effects on risk. Experimental studies have shown that high saturated fat and
omega-6 PUFAs increase the incidence of chemically induced colon cancer in animal
models (33), whereas omega-3 PUFAs inhibit colorectal carcinogenesis in rodents (34,35).
It has been suggested that the fat content, particularly saturated fat, in red meat may
influence CRC risk by increasing the production of secondary bile acids that can promote
colon carcinogenesis (11,36). Postulated mechanisms regarding the protective role for
omega-3 PUFAs include their ability to inhibit tumor growth and modulate the expression of
proinflammatory genes (37,38). There is limited evidence that foods containing animal fat
increase the risk of CRC (8). For example, a combined analysis of 13 case-control studies
found no evidence of an association between CRC and saturated fat, PUFAs, or MUFAs
(39). This is also the case for rectal cancer specifically, as studies have observed no
association between saturated fat and rectal cancer (27–30,40) as we did in this study for
distal CRC. High intake of PUFAs in our study was inversely related to risk but only
reached statistical significance in African Americans. However, it is possible that this was a
chance finding. Unfortunately, we were not able to distinguish between omega-3 and
omega-6 PUFAs.
Total consumption of protein was significantly associated with a significant risk reduction in
Whites and had a nonstatistically significant association with lower risk in African
Americans in this study. There is limited epidemiologic evidence for a relationship between
overall protein intake and distal CRC risk. A few studies have reported no association
between protein intake and rectal cancer risk (28,30), whereas a case-control study in Italy
reported a marginally significant risk reduction of rectal cancer for 100 calories/day from
protein (41). These results are contrary to the hypothesis that increased protein intake may
elevate CRC risk due to components of protein degradation such as ammonia, phenolic
compounds, amines, N-nitroso compounds, and possibly sulfides that are known to exert
toxic effects in animal models and in vitro (12). However, an animal study by Corpet et al.
(42) found that bacterial metabolites of protein did not promote colorectal carcinogenesis,
which challenges the previously mentioned hypothesis.
Meta-analyses of meat consumption and CRC risk have concluded that red meat and
processed meat increase the risk of CRC, colon cancer, and rectal cancer (3,9,43) and that
processed meat may be a stronger risk factor than fresh red meat (43,44). In contrast,
findings from individual studies have not been consistent (17,19,27,45–48); therefore, the
biological mechanisms relating red meat intake to CRC risk remain speculative. Individual
studies investigating the relationship between red meat and rectal cancer specifically are also
conflicting. Some studies have reported a significantly higher risk of rectal cancer with
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increased red meat consumption (17,46,48) whereas others did not find any statistically
significant associations (18,19,27,30,47,49,50). Our study did not suggest that red meat
intake elevates the risk of distal CRC, although moderately high intakes of processed meat
appear to be associated with significantly higher risk in Whites. Surprisingly, we found high
red meat consumption to be associated with lower risk in Whites.
It was initially hypothesized that the saturated fat and protein content of red meat increases
CRC risk for reasons previously mentioned. This hypothesis has been explored in animal
studies, and it was found that lean beef did not promote colon carcinogenesis in rats on high
calcium diets (51); therefore, the hypothesis may hold true when the diet is not overloaded
with calcium (13). This further suggests that other nutrients may modify the association
between red meat and CRC. When we controlled for energy from saturated fat in our
analyses of the risk estimates, there was a trend toward a slightly stronger risk reduction for
high red meat consumption in Whites. Therefore, there was little evidence indicating that the
association of red meat and distal CRC was mediated by saturated fat intake. Protein
metabolism is another mechanism to explain the relationship between CRC risk and red
meat intake. Meat is a major source of protein, and products of protein metabolism such as
ammonia and N-nitroso compounds are known to have toxic effects (12). High protein
intakes in this study appeared to reduce the risk of distal colorectal cancer in Whites, mainly
as the percent of total energy. Controlling for protein intake in the analyses of red meat and
distal CRC risk in Whites removed the significant risk reduction for high red meat intake
and strengthened the magnitude of the association with processed meat consumption.
Therefore, the protein content in red meat may contribute to distal CRC risk reduction in
Whites. This surprising finding may reflect that those with high red meat and protein intake
were generally more health conscious. For example, diets high in red meat and protein may
have been low in carbohydrate intake, and thereby reduce risk. However, low red meat
intake is usually associated with healthy dietary habits (52). In addition, this finding may
reflect the type of red meat consumed and how it was cooked, possibly minimizing the
presence of carcinogenic compounds in red meat cooked at high temperatures. No
statistically significant changes for were observed in African Americans, although there
were generally less favorable risk estimates when adjusting for protein.
Our findings do not support the hypotheses that fat, protein, and red meat increase the risk of
distal CRC, although these dietary components have generally been associated with elevated
colon cancer risk. There are several possible explanations for these findings. Our results may
simply reflect differences in proximal vs. distal colorectal cancer development. There is
evidence that colon and rectal cancer may have distinct etiologies (16,53) as well as
differences with regards to the metabolism of bile acids (14), expression of metabolizing
enzymes (15), bacterial composition and pH (54), and genetic profile (16,17). Another
explanation may be that red meat intake in our study population was relatively low, and
therefore perhaps below the level necessary to elevate risk. For example, Larsson and Wolk
(9) reported a 63% increase in rectal cancer risk associated with 120 g/day of red meat; the
mean total red meat intake in our study was 76 g/day. These results may also reflect our
inability to determine the amount of red meat consumed according to doneness and cooking
methods and thereby estimate the amount of heterocyclic amines and polycyclic aromatic
hydrocarbons in the red meat. These mutagenic compounds may be the culpable substances
more so than overall red meat consumption.
The reasons why some of our results differed by race are not totally clear. No other available
literature has reported the associations between diet and distal colorectal cancer in African
Americans. An early study of diet and colon cancer in African Americans did not observe
any statistically significant associations between colon cancer and beef and pork
consumption (55). A population-based case-control study of colon cancer did not report any
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associations between colon cancer risk in African Americans and energy-adjusted saturated
fat, protein, or red meat intakes (56,57). They did, however, find a significant colon cancer
risk reduction for high total fat intake in African Americans. We realize that the relatively
small sample of African Americans in our study may have resulted in reduced power to
detect real associations and resulted in unstable estimates. The risk differences remained
after we estimated ORs using the same quartile cut points in Whites and African Americans;
therefore, variation in the range of nutrient intake is also not a likely explanation for the
racial differences in risk.
The population-based design and large sample size are among the strengths of this study. It
is noteworthy that this is among the first published reports of associations between fat,
protein, red and processed meat, and distal CRC risk in African Americans. All data were
collected in person using standard questionnaires administered by our nurse interviewers,
thereby minimizing the potential for misclassification. Recall and response bias could have
been introduced in our study and affected our results. Specifically, the low response rate in
controls could have possibly inflated our risk estimates if they were healthier than the
general population. Also, the delay between cancer diagnosis and interview could have
contributed to recall bias. We also cannot exclude the possibility of measurement error due
to the use of the food frequency questionnaire. Given the multiple analyses in this study, the
statistically significant associations may have been due to chance and should be interpreted
with caution.
In summary, this study did not provide evidence that total or saturated fat is related to distal
CRC risk in Whites and African Americans. High intake of polyunsaturated fatty acids may
reduce distal CRC risk in African Americans, whereas protein intake may lower risk in
Whites. Red meat appeared to reduce risk, whereas processed meat may elevate risk in
Whites. These findings highlight the importance of examining these associations in large
racially diverse populations and add to the knowledge base for dietary risk factors for distal
CRC.
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5
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9
27
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9
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9
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0
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3
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4
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6/
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0
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0.
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.0
0
0.
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4
0.
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/3
9
10
8.
6
0.
64
0.
27
–1
.5
0
0.
80
0.
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P 
fo
r l
in
ea
r t
re
nd
0.
90
0.
94
Pr
oc
es
se
d 
m
ea
t (
g)
 
Q
1
13
1/
20
4
3.
4
1.
00
1.
00
1.
00
44
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1
3.
7
1.
00
1.
00
1.
00
 
Q
2
17
8/
20
2
9.
6
1.
15
0.
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–1
.6
2
1.
14
1.
21
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/4
0
12
.2
1.
47
0.
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–2
.8
5
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Q
3
20
8/
19
8
19
.1
1.
43
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–2
.0
2
1.
42
d
1.
56
d
42
/4
0
24
.9
0.
54
0.
24
–1
.1
8
0.
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Q
4
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3/
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6
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.7
1.
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–1
.6
8
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14
1.
36
54
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8
42
.7
0.
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0.
38
–1
.9
6
0.
59
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02
 
P 
fo
r l
in
ea
r t
re
nd
0.
57
0.
54
a N
 =
 1
,9
04
. A
dj
us
te
d 
fo
r a
ge
, s
ex
, e
du
ca
tio
n,
 b
od
y 
m
as
s i
nd
ex
 (B
M
I)
, f
am
ily
 h
is
to
ry
, n
on
st
er
oi
da
l a
nt
i-i
nf
la
m
m
at
or
y 
dr
ug
 (N
SA
ID
) u
se
, p
hy
si
ca
l a
ct
iv
ity
, c
al
ci
um
, f
ib
er
, a
nd
 to
ta
l e
ne
rg
y.
b A
dj
us
te
d 
fo
r a
ge
, s
ex
, e
du
ca
tio
n,
 B
M
I, 
fa
m
ily
 h
is
to
ry
, N
SA
ID
 u
se
, p
hy
si
ca
l a
ct
iv
ity
, c
al
ci
um
, f
ib
er
, t
ot
al
 e
ne
rg
y,
 a
nd
 e
ne
rg
y-
ad
ju
st
ed
 sa
tu
ra
te
d 
fa
t.
c A
dj
us
te
d 
fo
r a
ge
, s
ex
, e
du
ca
tio
n,
 B
M
I, 
fa
m
ily
 h
is
to
ry
, N
SA
ID
 u
se
, p
hy
si
ca
l a
ct
iv
ity
, c
al
ci
um
, f
ib
er
, t
ot
al
 e
ne
rg
y,
 a
nd
 e
ne
rg
y-
ad
ju
st
ed
 sa
tu
ra
te
d 
pr
ot
ei
n.
d P
 <
 0
.0
5.
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